Solid Neoplasm — Trials

Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 851–900 of 4,397 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04794699	Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion	active not recruiting	Phase 1	169	IDEAYA BiosciencesINDUSTRY	7	Apr 9, 2026	clinicaltrials
NCT06130254	Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers	terminated	Phase 1	1	M.D. Anderson Cancer CenterOTHER	1